Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Malaria Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Pre-Erythrocytic Vaccine
1.2.3 Erythrocytic Vaccine
1.2.4 Multi-antigen Vaccine
1.3 Market by Application
1.3.1 Global Malaria Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Community Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Malaria Vaccines Market Perspective (2018-2029)
2.2 Global Malaria Vaccines Growth Trends by Region
2.2.1 Malaria Vaccines Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Malaria Vaccines Historic Market Size by Region (2018-2024)
2.2.3 Malaria Vaccines Forecasted Market Size by Region (2024-2029)
2.3 Malaria Vaccines Market Dynamics
2.3.1 Malaria Vaccines Industry Trends
2.3.2 Malaria Vaccines Market Drivers
2.3.3 Malaria Vaccines Market Challenges
2.3.4 Malaria Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Malaria Vaccines by Players
3.1.1 Global Malaria Vaccines Revenue by Players (2018-2024)
3.1.2 Global Malaria Vaccines Revenue Market Share by Players (2018-2024)
3.2 Global Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Malaria Vaccines, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Malaria Vaccines Market Concentration Ratio
3.4.1 Global Malaria Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Malaria Vaccines Revenue in 2022
3.5 Global Key Players of Malaria Vaccines Head office and Area Served
3.6 Global Key Players of Malaria Vaccines, Product and Application
3.7 Global Key Players of Malaria Vaccines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Malaria Vaccines Breakdown Data by Type
4.1 Global Malaria Vaccines Historic Market Size by Type (2018-2024)
4.2 Global Malaria Vaccines Forecasted Market Size by Type (2024-2029)
5 Malaria Vaccines Breakdown Data by Application
5.1 Global Malaria Vaccines Historic Market Size by Application (2018-2024)
5.2 Global Malaria Vaccines Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Malaria Vaccines Market Size (2018-2029)
6.2 North America Malaria Vaccines Market Size by Type
6.2.1 North America Malaria Vaccines Market Size by Type (2018-2024)
6.2.2 North America Malaria Vaccines Market Size by Type (2024-2029)
6.2.3 North America Malaria Vaccines Market Share by Type (2018-2029)
6.3 North America Malaria Vaccines Market Size by Application
6.3.1 North America Malaria Vaccines Market Size by Application (2018-2024)
6.3.2 North America Malaria Vaccines Market Size by Application (2024-2029)
6.3.3 North America Malaria Vaccines Market Share by Application (2018-2029)
6.4 North America Malaria Vaccines Market Size by Country
6.4.1 North America Malaria Vaccines Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Malaria Vaccines Market Size by Country (2018-2024)
6.4.3 North America Malaria Vaccines Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Malaria Vaccines Market Size (2018-2029)
7.2 Europe Malaria Vaccines Market Size by Type
7.2.1 Europe Malaria Vaccines Market Size by Type (2018-2024)
7.2.2 Europe Malaria Vaccines Market Size by Type (2024-2029)
7.2.3 Europe Malaria Vaccines Market Share by Type (2018-2029)
7.3 Europe Malaria Vaccines Market Size by Application
7.3.1 Europe Malaria Vaccines Market Size by Application (2018-2024)
7.3.2 Europe Malaria Vaccines Market Size by Application (2024-2029)
7.3.3 Europe Malaria Vaccines Market Share by Application (2018-2029)
7.4 Europe Malaria Vaccines Market Size by Country
7.4.1 Europe Malaria Vaccines Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Malaria Vaccines Market Size by Country (2018-2024)
7.4.3 Europe Malaria Vaccines Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Malaria Vaccines Market Size (2018-2029)
8.2 China Malaria Vaccines Market Size by Type
8.2.1 China Malaria Vaccines Market Size by Type (2018-2024)
8.2.2 China Malaria Vaccines Market Size by Type (2024-2029)
8.2.3 China Malaria Vaccines Market Share by Type (2018-2029)
8.3 China Malaria Vaccines Market Size by Application
8.3.1 China Malaria Vaccines Market Size by Application (2018-2024)
8.3.2 China Malaria Vaccines Market Size by Application (2024-2029)
8.3.3 China Malaria Vaccines Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Malaria Vaccines Market Size (2018-2029)
9.2 Asia Malaria Vaccines Market Size by Type
9.2.1 Asia Malaria Vaccines Market Size by Type (2018-2024)
9.2.2 Asia Malaria Vaccines Market Size by Type (2024-2029)
9.2.3 Asia Malaria Vaccines Market Share by Type (2018-2029)
9.3 Asia Malaria Vaccines Market Size by Application
9.3.1 Asia Malaria Vaccines Market Size by Application (2018-2024)
9.3.2 Asia Malaria Vaccines Market Size by Application (2024-2029)
9.3.3 Asia Malaria Vaccines Market Share by Application (2018-2029)
9.4 Asia Malaria Vaccines Market Size by Region
9.4.1 Asia Malaria Vaccines Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Malaria Vaccines Market Size by Region (2018-2024)
9.4.3 Asia Malaria Vaccines Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Malaria Vaccines Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Malaria Vaccines Market Size by Type
10.2.1 Middle East, Africa, and Latin America Malaria Vaccines Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Malaria Vaccines Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Malaria Vaccines Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Malaria Vaccines Market Size by Application
10.3.1 Middle East, Africa, and Latin America Malaria Vaccines Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Malaria Vaccines Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Malaria Vaccines Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Malaria Vaccines Market Size by Country
10.4.1 Middle East, Africa, and Latin America Malaria Vaccines Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Malaria Vaccines Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Malaria Vaccines Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GlaxoSmithKline Plc
11.1.1 GlaxoSmithKline Plc Company Details
11.1.2 GlaxoSmithKline Plc Business Overview
11.1.3 GlaxoSmithKline Plc Malaria Vaccines Introduction
11.1.4 GlaxoSmithKline Plc Revenue in Malaria Vaccines Business (2018-2024)
11.1.5 GlaxoSmithKline Plc Recent Developments
11.2 Sanaria Inc
11.2.1 Sanaria Inc Company Details
11.2.2 Sanaria Inc Business Overview
11.2.3 Sanaria Inc Malaria Vaccines Introduction
11.2.4 Sanaria Inc Revenue in Malaria Vaccines Business (2018-2024)
11.2.5 Sanaria Inc Recent Developments
11.3 Nobelpharma Co
11.3.1 Nobelpharma Co Company Details
11.3.2 Nobelpharma Co Business Overview
11.3.3 Nobelpharma Co Malaria Vaccines Introduction
11.3.4 Nobelpharma Co Revenue in Malaria Vaccines Business (2018-2024)
11.3.5 Nobelpharma Co Recent Developments
11.4 Sumaya Biotech
11.4.1 Sumaya Biotech Company Details
11.4.2 Sumaya Biotech Business Overview
11.4.3 Sumaya Biotech Malaria Vaccines Introduction
11.4.4 Sumaya Biotech Revenue in Malaria Vaccines Business (2018-2024)
11.4.5 Sumaya Biotech Recent Developments
11.5 GenVec
11.5.1 GenVec Company Details
11.5.2 GenVec Business Overview
11.5.3 GenVec Malaria Vaccines Introduction
11.5.4 GenVec Revenue in Malaria Vaccines Business (2018-2024)
11.5.5 GenVec Recent Developments
11.6 Actiza Pharmaceutical Private Limited
11.6.1 Actiza Pharmaceutical Private Limited Company Details
11.6.2 Actiza Pharmaceutical Private Limited Business Overview
11.6.3 Actiza Pharmaceutical Private Limited Malaria Vaccines Introduction
11.6.4 Actiza Pharmaceutical Private Limited Revenue in Malaria Vaccines Business (2018-2024)
11.6.5 Actiza Pharmaceutical Private Limited Recent Developments
11.7 AdvaCare Pharma
11.7.1 AdvaCare Pharma Company Details
11.7.2 AdvaCare Pharma Business Overview
11.7.3 AdvaCare Pharma Malaria Vaccines Introduction
11.7.4 AdvaCare Pharma Revenue in Malaria Vaccines Business (2018-2024)
11.7.5 AdvaCare Pharma Recent Developments
11.8 Ipca Laboratories Ltd
11.8.1 Ipca Laboratories Ltd Company Details
11.8.2 Ipca Laboratories Ltd Business Overview
11.8.3 Ipca Laboratories Ltd Malaria Vaccines Introduction
11.8.4 Ipca Laboratories Ltd Revenue in Malaria Vaccines Business (2018-2024)
11.8.5 Ipca Laboratories Ltd Recent Developments
11.9 Bliss GVS Pharma Ltd
11.9.1 Bliss GVS Pharma Ltd Company Details
11.9.2 Bliss GVS Pharma Ltd Business Overview
11.9.3 Bliss GVS Pharma Ltd Malaria Vaccines Introduction
11.9.4 Bliss GVS Pharma Ltd Revenue in Malaria Vaccines Business (2018-2024)
11.9.5 Bliss GVS Pharma Ltd Recent Developments
11.10 GeoVax
11.10.1 GeoVax Company Details
11.10.2 GeoVax Business Overview
11.10.3 GeoVax Malaria Vaccines Introduction
11.10.4 GeoVax Revenue in Malaria Vaccines Business (2018-2024)
11.10.5 GeoVax Recent Developments
11.11 Pfizer Inc
11.11.1 Pfizer Inc Company Details
11.11.2 Pfizer Inc Business Overview
11.11.3 Pfizer Inc Malaria Vaccines Introduction
11.11.4 Pfizer Inc Revenue in Malaria Vaccines Business (2018-2024)
11.11.5 Pfizer Inc Recent Developments
11.12 VLP Therapeutics
11.12.1 VLP Therapeutics Company Details
11.12.2 VLP Therapeutics Business Overview
11.12.3 VLP Therapeutics Malaria Vaccines Introduction
11.12.4 VLP Therapeutics Revenue in Malaria Vaccines Business (2018-2024)
11.12.5 VLP Therapeutics Recent Developments
11.13 OSIVAX
11.13.1 OSIVAX Company Details
11.13.2 OSIVAX Business Overview
11.13.3 OSIVAX Malaria Vaccines Introduction
11.13.4 OSIVAX Revenue in Malaria Vaccines Business (2018-2024)
11.13.5 OSIVAX Recent Developments
11.14 AJANTA PHARMA
11.14.1 AJANTA PHARMA Company Details
11.14.2 AJANTA PHARMA Business Overview
11.14.3 AJANTA PHARMA Malaria Vaccines Introduction
11.14.4 AJANTA PHARMA Revenue in Malaria Vaccines Business (2018-2024)
11.14.5 AJANTA PHARMA Recent Developments
11.15 Strides Pharma Science Limited
11.15.1 Strides Pharma Science Limited Company Details
11.15.2 Strides Pharma Science Limited Business Overview
11.15.3 Strides Pharma Science Limited Malaria Vaccines Introduction
11.15.4 Strides Pharma Science Limited Revenue in Malaria Vaccines Business (2018-2024)
11.15.5 Strides Pharma Science Limited Recent Developments
11.16 Mylan N.V.
11.16.1 Mylan N.V. Company Details
11.16.2 Mylan N.V. Business Overview
11.16.3 Mylan N.V. Malaria Vaccines Introduction
11.16.4 Mylan N.V. Revenue in Malaria Vaccines Business (2018-2024)
11.16.5 Mylan N.V. Recent Developments
11.17 Zydus Cadila
11.17.1 Zydus Cadila Company Details
11.17.2 Zydus Cadila Business Overview
11.17.3 Zydus Cadila Malaria Vaccines Introduction
11.17.4 Zydus Cadila Revenue in Malaria Vaccines Business (2018-2024)
11.17.5 Zydus Cadila Recent Developments
11.18 Cipla Inc
11.18.1 Cipla Inc Company Details
11.18.2 Cipla Inc Business Overview
11.18.3 Cipla Inc Malaria Vaccines Introduction
11.18.4 Cipla Inc Revenue in Malaria Vaccines Business (2018-2024)
11.18.5 Cipla Inc Recent Developments
11.19 Sun Pharmaceutical Industries Ltd
11.19.1 Sun Pharmaceutical Industries Ltd Company Details
11.19.2 Sun Pharmaceutical Industries Ltd Business Overview
11.19.3 Sun Pharmaceutical Industries Ltd Malaria Vaccines Introduction
11.19.4 Sun Pharmaceutical Industries Ltd Revenue in Malaria Vaccines Business (2018-2024)
11.19.5 Sun Pharmaceutical Industries Ltd Recent Developments
11.20 Sanofi
11.20.1 Sanofi Company Details
11.20.2 Sanofi Business Overview
11.20.3 Sanofi Malaria Vaccines Introduction
11.20.4 Sanofi Revenue in Malaria Vaccines Business (2018-2024)
11.20.5 Sanofi Recent Developments
11.21 Hikma Pharmaceuticals PLC
11.21.1 Hikma Pharmaceuticals PLC Company Details
11.21.2 Hikma Pharmaceuticals PLC Business Overview
11.21.3 Hikma Pharmaceuticals PLC Malaria Vaccines Introduction
11.21.4 Hikma Pharmaceuticals PLC Revenue in Malaria Vaccines Business (2018-2024)
11.21.5 Hikma Pharmaceuticals PLC Recent Developments
11.22 Amneal Pharmaceuticals LLC
11.22.1 Amneal Pharmaceuticals LLC Company Details
11.22.2 Amneal Pharmaceuticals LLC Business Overview
11.22.3 Amneal Pharmaceuticals LLC Malaria Vaccines Introduction
11.22.4 Amneal Pharmaceuticals LLC Revenue in Malaria Vaccines Business (2018-2024)
11.22.5 Amneal Pharmaceuticals LLC Recent Developments
11.23 Taj Pharmaceuticals Limited
11.23.1 Taj Pharmaceuticals Limited Company Details
11.23.2 Taj Pharmaceuticals Limited Business Overview
11.23.3 Taj Pharmaceuticals Limited Malaria Vaccines Introduction
11.23.4 Taj Pharmaceuticals Limited Revenue in Malaria Vaccines Business (2018-2024)
11.23.5 Taj Pharmaceuticals Limited Recent Developments
11.24 Lupin
11.24.1 Lupin Company Details
11.24.2 Lupin Business Overview
11.24.3 Lupin Malaria Vaccines Introduction
11.24.4 Lupin Revenue in Malaria Vaccines Business (2018-2024)
11.24.5 Lupin Recent Developments
11.25 Novartis AG
11.25.1 Novartis AG Company Details
11.25.2 Novartis AG Business Overview
11.25.3 Novartis AG Malaria Vaccines Introduction
11.25.4 Novartis AG Revenue in Malaria Vaccines Business (2018-2024)
11.25.5 Novartis AG Recent Developments
11.26 CellFree Sciences
11.26.1 CellFree Sciences Company Details
11.26.2 CellFree Sciences Business Overview
11.26.3 CellFree Sciences Malaria Vaccines Introduction
11.26.4 CellFree Sciences Revenue in Malaria Vaccines Business (2018-2024)
11.26.5 CellFree Sciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Malaria Vaccines Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Pre-Erythrocytic Vaccine
Table 3. Key Players of Erythrocytic Vaccine
Table 4. Key Players of Multi-antigen Vaccine
Table 5. Global Malaria Vaccines Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Malaria Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Malaria Vaccines Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Malaria Vaccines Market Share by Region (2018-2024)
Table 9. Global Malaria Vaccines Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Malaria Vaccines Market Share by Region (2024-2029)
Table 11. Malaria Vaccines Market Trends
Table 12. Malaria Vaccines Market Drivers
Table 13. Malaria Vaccines Market Challenges
Table 14. Malaria Vaccines Market Restraints
Table 15. Global Malaria Vaccines Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Malaria Vaccines Revenue Share by Players (2018-2024)
Table 17. Global Top Malaria Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malaria Vaccines as of 2022)
Table 18. Global Malaria Vaccines Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Malaria Vaccines Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Malaria Vaccines, Headquarters and Area Served
Table 21. Global Key Players of Malaria Vaccines, Product and Application
Table 22. Global Key Players of Malaria Vaccines, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Malaria Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Malaria Vaccines Revenue Market Share by Type (2018-2024)
Table 26. Global Malaria Vaccines Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Malaria Vaccines Revenue Market Share by Type (2024-2029)
Table 28. Global Malaria Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Malaria Vaccines Revenue Share by Application (2018-2024)
Table 30. Global Malaria Vaccines Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Malaria Vaccines Revenue Share by Application (2024-2029)
Table 32. North America Malaria Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Malaria Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Malaria Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Malaria Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Malaria Vaccines Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Malaria Vaccines Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Malaria Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Malaria Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Malaria Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Malaria Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Malaria Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Malaria Vaccines Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Malaria Vaccines Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Malaria Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Malaria Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Malaria Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Malaria Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Malaria Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Malaria Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Malaria Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Malaria Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Malaria Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Malaria Vaccines Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Malaria Vaccines Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Malaria Vaccines Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Malaria Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Malaria Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Malaria Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Malaria Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Malaria Vaccines Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Malaria Vaccines Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Malaria Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 64. GlaxoSmithKline Plc Company Details
Table 65. GlaxoSmithKline Plc Business Overview
Table 66. GlaxoSmithKline Plc Malaria Vaccines Product
Table 67. GlaxoSmithKline Plc Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 68. GlaxoSmithKline Plc Recent Developments
Table 69. Sanaria Inc Company Details
Table 70. Sanaria Inc Business Overview
Table 71. Sanaria Inc Malaria Vaccines Product
Table 72. Sanaria Inc Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 73. Sanaria Inc Recent Developments
Table 74. Nobelpharma Co Company Details
Table 75. Nobelpharma Co Business Overview
Table 76. Nobelpharma Co Malaria Vaccines Product
Table 77. Nobelpharma Co Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 78. Nobelpharma Co Recent Developments
Table 79. Sumaya Biotech Company Details
Table 80. Sumaya Biotech Business Overview
Table 81. Sumaya Biotech Malaria Vaccines Product
Table 82. Sumaya Biotech Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 83. Sumaya Biotech Recent Developments
Table 84. GenVec Company Details
Table 85. GenVec Business Overview
Table 86. GenVec Malaria Vaccines Product
Table 87. GenVec Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 88. GenVec Recent Developments
Table 89. Actiza Pharmaceutical Private Limited Company Details
Table 90. Actiza Pharmaceutical Private Limited Business Overview
Table 91. Actiza Pharmaceutical Private Limited Malaria Vaccines Product
Table 92. Actiza Pharmaceutical Private Limited Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 93. Actiza Pharmaceutical Private Limited Recent Developments
Table 94. AdvaCare Pharma Company Details
Table 95. AdvaCare Pharma Business Overview
Table 96. AdvaCare Pharma Malaria Vaccines Product
Table 97. AdvaCare Pharma Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 98. AdvaCare Pharma Recent Developments
Table 99. Ipca Laboratories Ltd Company Details
Table 100. Ipca Laboratories Ltd Business Overview
Table 101. Ipca Laboratories Ltd Malaria Vaccines Product
Table 102. Ipca Laboratories Ltd Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 103. Ipca Laboratories Ltd Recent Developments
Table 104. Bliss GVS Pharma Ltd Company Details
Table 105. Bliss GVS Pharma Ltd Business Overview
Table 106. Bliss GVS Pharma Ltd Malaria Vaccines Product
Table 107. Bliss GVS Pharma Ltd Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 108. Bliss GVS Pharma Ltd Recent Developments
Table 109. GeoVax Company Details
Table 110. GeoVax Business Overview
Table 111. GeoVax Malaria Vaccines Product
Table 112. GeoVax Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 113. GeoVax Recent Developments
Table 114. Pfizer Inc Company Details
Table 115. Pfizer Inc Business Overview
Table 116. Pfizer Inc Malaria Vaccines Product
Table 117. Pfizer Inc Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 118. Pfizer Inc Recent Developments
Table 119. VLP Therapeutics Company Details
Table 120. VLP Therapeutics Business Overview
Table 121. VLP Therapeutics Malaria Vaccines Product
Table 122. VLP Therapeutics Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 123. VLP Therapeutics Recent Developments
Table 124. OSIVAX Company Details
Table 125. OSIVAX Business Overview
Table 126. OSIVAX Malaria Vaccines Product
Table 127. OSIVAX Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 128. OSIVAX Recent Developments
Table 129. AJANTA PHARMA Company Details
Table 130. AJANTA PHARMA Business Overview
Table 131. AJANTA PHARMA Malaria Vaccines Product
Table 132. AJANTA PHARMA Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 133. AJANTA PHARMA Recent Developments
Table 134. Strides Pharma Science Limited Company Details
Table 135. Strides Pharma Science Limited Business Overview
Table 136. Strides Pharma Science Limited Malaria Vaccines Product
Table 137. Strides Pharma Science Limited Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 138. Strides Pharma Science Limited Recent Developments
Table 139. Mylan N.V. Company Details
Table 140. Mylan N.V. Business Overview
Table 141. Mylan N.V. Malaria Vaccines Product
Table 142. Mylan N.V. Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 143. Mylan N.V. Recent Developments
Table 144. Zydus Cadila Company Details
Table 145. Zydus Cadila Business Overview
Table 146. Zydus Cadila Malaria Vaccines Product
Table 147. Zydus Cadila Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 148. Zydus Cadila Recent Developments
Table 149. Cipla Inc Company Details
Table 150. Cipla Inc Business Overview
Table 151. Cipla Inc Malaria Vaccines Product
Table 152. Cipla Inc Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 153. Cipla Inc Recent Developments
Table 154. Sun Pharmaceutical Industries Ltd Company Details
Table 155. Sun Pharmaceutical Industries Ltd Business Overview
Table 156. Sun Pharmaceutical Industries Ltd Malaria Vaccines Product
Table 157. Sun Pharmaceutical Industries Ltd Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 158. Sun Pharmaceutical Industries Ltd Recent Developments
Table 159. Sanofi Company Details
Table 160. Sanofi Business Overview
Table 161. Sanofi Malaria Vaccines Product
Table 162. Sanofi Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 163. Sanofi Recent Developments
Table 164. Hikma Pharmaceuticals PLC Company Details
Table 165. Hikma Pharmaceuticals PLC Business Overview
Table 166. Hikma Pharmaceuticals PLC Malaria Vaccines Product
Table 167. Hikma Pharmaceuticals PLC Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 168. Hikma Pharmaceuticals PLC Recent Developments
Table 169. Amneal Pharmaceuticals LLC Company Details
Table 170. Amneal Pharmaceuticals LLC Business Overview
Table 171. Amneal Pharmaceuticals LLC Malaria Vaccines Product
Table 172. Amneal Pharmaceuticals LLC Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 173. Amneal Pharmaceuticals LLC Recent Developments
Table 174. Taj Pharmaceuticals Limited Company Details
Table 175. Taj Pharmaceuticals Limited Business Overview
Table 176. Taj Pharmaceuticals Limited Malaria Vaccines Product
Table 177. Taj Pharmaceuticals Limited Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 178. Taj Pharmaceuticals Limited Recent Developments
Table 179. Lupin Company Details
Table 180. Lupin Business Overview
Table 181. Lupin Malaria Vaccines Product
Table 182. Lupin Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 183. Lupin Recent Developments
Table 184. Novartis AG Company Details
Table 185. Novartis AG Business Overview
Table 186. Novartis AG Malaria Vaccines Product
Table 187. Novartis AG Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 188. Novartis AG Recent Developments
Table 189. CellFree Sciences Company Details
Table 190. CellFree Sciences Business Overview
Table 191. CellFree Sciences Malaria Vaccines Product
Table 192. CellFree Sciences Revenue in Malaria Vaccines Business (2018-2024) & (US$ Million)
Table 193. CellFree Sciences Recent Developments
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Malaria Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Malaria Vaccines Market Share by Type: 2022 VS 2029
Figure 3. Pre-Erythrocytic Vaccine Features
Figure 4. Erythrocytic Vaccine Features
Figure 5. Multi-antigen Vaccine Features
Figure 6. Global Malaria Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Malaria Vaccines Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Community Centers Case Studies
Figure 11. Malaria Vaccines Report Years Considered
Figure 12. Global Malaria Vaccines Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Malaria Vaccines Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Malaria Vaccines Market Share by Region: 2022 VS 2029
Figure 15. Global Malaria Vaccines Market Share by Players in 2022
Figure 16. Global Top Malaria Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malaria Vaccines as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Malaria Vaccines Revenue in 2022
Figure 18. North America Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Malaria Vaccines Market Share by Type (2018-2029)
Figure 20. North America Malaria Vaccines Market Share by Application (2018-2029)
Figure 21. North America Malaria Vaccines Market Share by Country (2018-2029)
Figure 22. United States Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Malaria Vaccines Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Malaria Vaccines Market Share by Type (2018-2029)
Figure 26. Europe Malaria Vaccines Market Share by Application (2018-2029)
Figure 27. Europe Malaria Vaccines Market Share by Country (2018-2029)
Figure 28. Germany Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Malaria Vaccines Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Malaria Vaccines Market Share by Type (2018-2029)
Figure 36. China Malaria Vaccines Market Share by Application (2018-2029)
Figure 37. Asia Malaria Vaccines Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Malaria Vaccines Market Share by Type (2018-2029)
Figure 39. Asia Malaria Vaccines Market Share by Application (2018-2029)
Figure 40. Asia Malaria Vaccines Market Share by Region (2018-2029)
Figure 41. Japan Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Malaria Vaccines Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Malaria Vaccines Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Malaria Vaccines Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Malaria Vaccines Market Share by Country (2018-2029)
Figure 51. Brazil Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GlaxoSmithKline Plc Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 58. Sanaria Inc Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 59. Nobelpharma Co Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 60. Sumaya Biotech Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 61. GenVec Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 62. Actiza Pharmaceutical Private Limited Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 63. AdvaCare Pharma Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 64. Ipca Laboratories Ltd Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 65. Bliss GVS Pharma Ltd Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 66. GeoVax Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 67. Pfizer Inc Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 68. VLP Therapeutics Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 69. OSIVAX Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 70. AJANTA PHARMA Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 71. Strides Pharma Science Limited Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 72. Mylan N.V. Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 73. Zydus Cadila Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 74. Cipla Inc Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 75. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 76. Sanofi Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 77. Hikma Pharmaceuticals PLC Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 78. Amneal Pharmaceuticals LLC Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 79. Taj Pharmaceuticals Limited Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 80. Lupin Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 81. Novartis AG Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 82. CellFree Sciences Revenue Growth Rate in Malaria Vaccines Business (2018-2024)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed